Levothyroxine Sodium Tablet
Product Images NDC 82868-001

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Levothyroxine Sodium (NDC 82868-001). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image-1 (34dea88d F273 46cd 9240 2b63f15cc132 01)

Chemical structure diagram of Levothyroxine Sodium showing iodine-substituted aromatic rings connected through an ether bond, with a side chain including an amino group, carboxylate sodium salt, and associated water molecules.*

FDA Label Image

Label (82868 001 30 Master Bottle Label Approval Rev A 07 23)

Label for Levothyroxine Sodium Tablets, USP 0.2 mg (200 mcg) oral tablets, containing 30 tablets per container. The label includes storage instructions, lot information, and is labeled for prescription use only. The product is repackaged by Northwind Pharmaceuticals, Indianapolis, IN.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.